BACKGROUND: The prompt initial use of appropriate antibiotics should improve mortality
rates in adults with ventilator-associated pneumonia (VAP). However, the incidence of …

Initial antibiotic therapy is an important determinant of clinical outcomes in ventilator-
associated pneumonia (VAP). Several studies have investigated this issue, with conflicting …

PURPOSE: The aim of this study was to investigate modifiable risk factors and predictors for
treatment failure (TF) in patients with ventilator-associated pneumonia (VAP) receiving …

Objective: Early recognition of predictors of unfavorable evolution of ventilator-associated
pneumonia (VAP) might prompt therapeutic measures that might improve outcome. The …

Background: The initial empirical therapy of Ventilator Associated Pneumonia (VAP)
modified based on the knowledge of local microbiological data is associated with decreased …

Objective To identify predictors of 30-day mortality and hospital costs in patients with
ventilator-associated pneumonia (VAP) attributed to potentially antibiotic-resistant Gram …

Objective To study the prognostic impact of the appropriateness of initial antimicrobial
therapy in patients suffering from ventilator-associated pneumonia (VAP). Design and …

Study objectives To describe the variation in clinical practice strategies for the treatment of
suspected ventilator-associated pneumonia (VAP) in a population of critically ill patients …

OBJECTIVE: The individual impact of timeliness vs adequacy of empiric antibiotic therapy for
a clinical suspicion of ventilator-associated pneumonia (CSVAP) is unknown. Accordingly, in …

Background Mechanical ventilation (MV) is often applied in critically ill patients in intensive
care unit (ICU) to protect the airway from aspiration, and supplement more oxygen. MV may …